Figure 1.
Endogenous miR-299-3p expression in PCa cell lines and tissues and miR-299-3p overexpression decreased cell proliferation. (A) Average fold change in expression of miR-299-3p prostate tumor tissues (n = 15) compared to matched uninvolved areas (15), and 3 additional tumor tissues. (B) TCGA database analysis showing significant loss of expression of miR-299-3p in prostate tumors compared to normal tissues. (C) Quantitative RT-PCR showing relative fold change in miR-299-3p expression in PCa cell lines compared to non-tumorigenic RWPE-1 cells. Raw data have been normalized to the mean of RNU43, U6 and U1 snRNA. (D,E) Cell proliferation assays showing significantly reduced cell growth in miR-299-3p overexpressing cells. Data represent mean ± standard deviation (SD) of at least three independent assays in triplicates. C4-2B and 22Rv-1 cells stably transfected (D) and PC-3 cells transiently transfected (E) with inducible DNA constructs for miR-299-3p precursor miRNA or scrambled (Scr) RNA (PC-3) were induced (PC-3 at 24 h post transfection) and cell proliferation at 48 hr were detected by MTS assays. (F) Analysis of Ki67+ cells upon immunofluorescence staining for Ki67 performed at 72 hr post induction showing significant reduction in Ki67+ C4-2B and 22Rv-1 cells overexpressing miR-299-3p.